Glenn R. Larsen, Director at Anika Therapeutics, Inc. (ANIK), sold 8,710 shares at $57.21 ($498K) on 2019-08-28, disclosed to the SEC on 2019-08-30.
Open-market sale of $498k ANIK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.21 | 4,355 | $249K | 50.0% |
| 2 | $57.21 | 4,355 | $249K | 50.0% |
| Total | $57.21 avg | 8,710 | $498K | 100% |